Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...
SpotDraft, the Bengaluru headquartered technology startup that provides contract lifecycle management (CLM) software platform ...
GlobalData on MSN12d
FDA approves Vertex’s acute pain treatment JournavxThe FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.
That’s the opinion of top Vertex Pharmaceuticals executives and several market analysts about the Boston-based company’s painkiller Journavx, which the Food and Drug Administration approved on ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
Furthermore, TOMRA's LASER sorting technology effectively separates gold-bearing quartz ore from waste materials such as slate and greywacke before it enters the processing plant. Vertex believes ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...
"FDA approves Vertex’s acute pain treatment Journavx" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback